Work

2501 ORAL A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)31323-5

Authors: B. Montgomery, A. Joshua, M. Gleave, N. Fleshner, G. Bubley, L. True, M. Tretiakova, K. Wu, W. Novotny, A. Peterson, A. Amelsberg, M.E. Taplin

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2518181562

FWCI:

Cites:

Cited by:

Related to: 10